Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Evogene Ltd.
Nieuws
Evogene Ltd.
EVGN
NAS
: EVGN
| ISIN: IL0011050551
1/05/2025
1,150 USD
(+1,77%)
(+1,77%)
1/05/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Technische analyse
TA
Toon enkel gratis nieuws
21 april 2025 ·
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
· Persbericht
6 maart 2025 ·
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
· Persbericht
6 maart 2025 ·
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
· Persbericht
23 augustus 2024 ·
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
· Persbericht
22 augustus 2024 ·
Evogene Reports Second Quarter 2024 Financial Results
· Persbericht
12 augustus 2024 ·
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
· Persbericht
12 augustus 2024 ·
Evogene Schedules Second Quarter 2024 Financial Results Release
· Persbericht
31 juli 2024 ·
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
· Persbericht
23 juli 2024 ·
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
· Persbericht
17 juli 2024 ·
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
· Persbericht
2 juli 2024 ·
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat
· Persbericht
25 juni 2024 ·
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
· Persbericht
23 mei 2024 ·
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
· Persbericht
23 mei 2024 ·
Evogene Reports First Quarter 2024 Financial Results
· Persbericht
21 mei 2024 ·
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
· Persbericht
9 mei 2024 ·
Evogene Schedules First Quarter 2024 Financial Results Release
· Persbericht
16 april 2024 ·
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
· Persbericht
11 april 2024 ·
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
· Persbericht
2 april 2024 ·
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
· Persbericht
28 maart 2024 ·
Evogene Announces Filing of Annual Report on Form 20-F
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe